Patents by Inventor Itai Bloch

Itai Bloch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260226403
    Abstract: The present invention provides is directed to a method of producing an amino acid, including: (a) providing a bacterial cell including an exogenous nucleic acid molecule or a plurality thereof encoding metX and metY; and culturing the bacterial cell from step (a) such that metX and metY encoded by an exogenous nucleic acid molecule are expressed, bacterial cell including: (i) an exogenous nucleic acid molecule or a plurality thereof, encoding homoserine O-acetyltransferase (metX) and O-acetylhomoserine sulfhydrylase (metY). Further provided are a composition comprising the bacterial cell, and a method for producing amino acids.
    Type: Application
    Filed: December 21, 2023
    Publication date: August 6, 2026
    Inventors: Maayan GAL, Rachel AMIR, Yael HACHAM, Nadia GRUZDEV, Hadar HAVIV, Itamar YADID, Itai BLOCH
  • Publication number: 20260060277
    Abstract: The present invention provides an edible composition including at least one: recombinant pigeon ovalbumin, recombinant hamerkop ovalbumin, or recombinant collard flycatcher ovalbumin. Further provided are a food product including the edible composition of the invention, as well as a method for preparing same.
    Type: Application
    Filed: August 22, 2023
    Publication date: March 5, 2026
    Applicants: EGGMENTED REALITY LTD., MIGAL GALILEE RESEARCH INSTITUTE LTD.
    Inventors: Itai BLOCH, Itamar YADID, Tamar MEIRON
  • Publication number: 20250163133
    Abstract: SIRPalpha-4-1BBL variant fusion proteins are provided. Also provided are isolated polypeptides comprising a SIRPalpha variant. Also provided are polynucleotides and nucleic acid constructs encoding the SIRPalpha-41BBL fusion protein or the isolated polypeptide, host-cells expressing same and methods of use thereof.
    Type: Application
    Filed: January 17, 2025
    Publication date: May 22, 2025
    Applicant: KAHR Medical Ltd.
    Inventors: Iris PECKER, Itai BLOCH
  • Patent number: 12286466
    Abstract: PD1-4-1BBL variant fusion proteins are provided. Also provided are isolated polypeptides comprising a PD1 variant or a 4-1BBL variant. Also provided are polynucleotides and nucleic acid constructs encoding the PD1-4-1BBL fusion protein or the isolated polypeptide, host-cells expressing the same and methods of use thereof.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: April 29, 2025
    Assignee: KAHR Medical Ltd.
    Inventors: Iris Pecker, Itai Bloch
  • Publication number: 20250051410
    Abstract: LILRB polypeptides are provided. Accordingly, there is provided a LILRB polypeptide capable of binding an HLA-G polypeptide as set forth in SEQ ID NO: 3 and having at least one mutation located within amino acid positions 40-60 of a D1 domain of LILRB, wherein the LILRB polypeptide has an increased stability and/or increased affinity to HLA-G compared to a LILRB polypeptide of the same length and sequence not comprising the at least one mutation. Also provided are polynucleotides encoding the LILRB polypeptide, host cells expressing the LILRB polypeptide and methods of producing and using same.
    Type: Application
    Filed: December 22, 2022
    Publication date: February 13, 2025
    Applicant: KAHR Medical Ltd.
    Inventors: Ami TAMIR, Itai BLOCH
  • Publication number: 20250026809
    Abstract: SIRPalpha-4-1BBL variant fusion proteins are provided. Also provided are isolated polypeptides comprising a SIRPalpha variant. Also provided are polynucleotides and nucleic acid constructs encoding the SIRPalpha-41BBL fusion protein or the isolated polypeptide, host-cells expressing same and methods of use thereof.
    Type: Application
    Filed: October 2, 2024
    Publication date: January 23, 2025
    Applicant: KAHR Medical Ltd.
    Inventors: Iris PECKER, Itai BLOCH
  • Publication number: 20250008959
    Abstract: Provided herein are compounds that inhibit the protein-protein interaction of serine acetyltransferase (SAT) with O-acetyl serine sulfhydrylase (OASS), and can therefore be used as herbicides.
    Type: Application
    Filed: October 10, 2022
    Publication date: January 9, 2025
    Applicant: Projini Agchem LTD
    Inventors: Nesly DOTAN, Itai BLOCH, Maayan GAL, Elad COHEN, Rotem BEN-SHUSHAN SHELLY, Eytan AMRAM
  • Patent number: 12134638
    Abstract: SIRPalpha-4-1BBL variant fusion proteins are provided. Also provided are isolated polypeptides comprising a SIRPalpha variant. Also provided are polynucleotides and nucleic acid constructs encoding the SIRPalpha-41BBL fusion protein or the isolated polypeptide, host-cells expressing same and methods of use thereof.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: November 5, 2024
    Assignee: KAHR Medical Ltd.
    Inventors: Iris Pecker, Itai Bloch
  • Publication number: 20230250086
    Abstract: The present invention provides novel inhibitors of cystathionin gamma synthase (CGS), their use as selective and non-selective herbicides, agricultural and non-agricultural herbicides, herbicides in integrated pest management, herbicides for gardening, clearing waste ground, clearing industrial or constructions sites, clearing railways and railway embankments, pesticide, fungicide, agricultural plant stimulant or antimicrobial agent. Also provided is a method for the control of undesired vegetation or clearing areas from the undesired vegetation comprising applying to the locus of said undesired vegetation, to the undesired plants or to a habitat thereof, a herbicidally effective amount of the compound of the present invention.
    Type: Application
    Filed: April 4, 2023
    Publication date: August 10, 2023
    Inventors: Itai BLOCH, Elad COHEN, Rachel AMIR, Maayan GAL
  • Publication number: 20230232828
    Abstract: The present invention provides novel sulphonamide inhibitors of cystathionin gamma synthase (CGS), their use as selective and non-selective herbicides, agricultural and non-agricultural herbicides, herbicides in integrated pest management, herbicides for gardening, clearing waste ground, clearing industrial or constructions sites, clearing railways and railway embankments, pesticide, fungicide, agricultural plant stimulant or antimicrobial agent. Also provided is a method for the control of undesired vegetation or clearing areas from the undesired vegetation comprising applying to the locus of said undesired vegetation, to the undesired plants or to a habitat thereof, a herbicidally effective amount of the compound of the present invention.
    Type: Application
    Filed: April 4, 2023
    Publication date: July 27, 2023
    Inventors: Itai BLOCH, Elad COHEN, Rachel AMIR, Maayan GAL
  • Publication number: 20230190923
    Abstract: The present invention is directed to compositions of immunogenic polypeptides including a heat labile toxin subunit B (LTB) polypeptide and a plurality of viral polypeptides. Further provided are compositions and methods of using same, such as for vaccinating a subject in need thereof.
    Type: Application
    Filed: February 25, 2021
    Publication date: June 22, 2023
    Applicant: MIGAL GALILEE RESEARCH INSTITUTE LTD.
    Inventors: Jacob PITCOVSKI, Ehud SHAHAR, Itai BLOCH, Itamar YADID, Ran BEN ADIVA, Chen KATZ, Nady GRUZDEV
  • Patent number: 11647748
    Abstract: The present invention provides novel sulphonamide inhibitors of cystathionin gamma synthase (CGS), their use as selective and non-selective herbicides, agricultural and non-agricultural herbicides, herbicides in integrated pest management, herbicides for gardening, clearing waste ground, clearing industrial or constructions sites, clearing railways and railway embankments, pesticide, fungicide, agricultural plant stimulant or antimicrobial agent. Also provided is a method for the control of undesired vegetation or clearing areas from the undesired vegetation comprising applying to the locus of said undesired vegetation, to the undesired plants or to a habitat thereof, a herbicidally effective amount of the compound of the present invention.
    Type: Grant
    Filed: July 1, 2020
    Date of Patent: May 16, 2023
    Assignee: MIGAL—GALILEE RESEARCH INSTITUTE LTD.
    Inventors: Itai Bloch, Elad Cohen, Rachel Amir, Maayan Gal
  • Patent number: 11639345
    Abstract: The present invention provides novel inhibitors of cystathionin gamma synthase (CGS), their use as selective and non-selective herbicides, agricultural and non-agricultural herbicides, herbicides in integrated pest management, herbicides for gardening, clearing waste ground, clearing industrial or constructions sites, clearing railways and railway embankments, pesticide, fungicide, agricultural plant stimulant or antimicrobial agent. Also provided is a method for the control of undesired vegetation or clearing areas from the undesired vegetation comprising applying to the locus of said undesired vegetation, to the undesired plants or to a habitat thereof, a herbicidally effective amount of the compound of the present invention.
    Type: Grant
    Filed: July 1, 2020
    Date of Patent: May 2, 2023
    Assignee: MIGAL—GALILEE RESEARCH INSTITUTE LTD.
    Inventors: Itai Bloch, Elad Cohen, Rachel Amir, Maayan Gal
  • Publication number: 20210284711
    Abstract: PD1-4-1BBL variant fusion proteins are provided. Also provided are isolated polypeptides comprising a PD1 variant or a 4-1BBL variant. Also provided are polynucleotides and nucleic acid constructs encoding the PD1-4-1BBL fusion protein or the isolated polypeptide, host-cells expressing the same and methods of use thereof.
    Type: Application
    Filed: July 11, 2019
    Publication date: September 16, 2021
    Applicant: KAHR Medical Ltd.
    Inventors: Iris PECKER, Itai BLOCH
  • Publication number: 20210214417
    Abstract: SIRPalpha-4-1BBL variant fusion proteins are provided. Also provided are isolated polypeptides comprising a SIRPalpha variant. Also provided are polynucleotides and nucleic acid constructs encoding the SIRPalpha-41BBL fusion protein or the isolated polypeptide, host-cells expressing same and methods of use thereof.
    Type: Application
    Filed: July 11, 2019
    Publication date: July 15, 2021
    Applicant: KAHR Medical Ltd.
    Inventors: Iris PECKER, Itai BLOCH
  • Publication number: 20200331872
    Abstract: The present invention provides novel inhibitors of cystathionin gamma synthase (CGS), their use as selective and non-selective herbicides, agricultural and non-agricultural herbicides, herbicides in integrated pest management, herbicides for gardening, clearing waste ground, clearing industrial or constructions sites, clearing railways and railway embankments, pesticide, fungicide, agricultural plant stimulant or antimicrobial agent. Also provided is a method for the control of undesired vegetation or clearing areas from the undesired vegetation comprising applying to the locus of said undesired vegetation, to the undesired plants or to a habitat thereof, a herbicidally effective amount of the compound of the present invention.
    Type: Application
    Filed: July 1, 2020
    Publication date: October 22, 2020
    Inventors: Itai BLOCH, Elad COHEN, Rachel AMIR, Maayan GAL
  • Publication number: 20200329705
    Abstract: The present invention provides novel sulphonamide inhibitors of cystathionin gamma synthase (CGS), their use as selective and non-selective herbicides, agricultural and non-agricultural herbicides, herbicides in integrated pest management, herbicides for gardening, clearing waste ground, clearing industrial or constructions sites, clearing railways and railway embankments, pesticide, fungicide, agricultural plant stimulant or antimicrobial agent. Also provided is a method for the control of undesired vegetation or clearing areas from the undesired vegetation comprising applying to the locus of said undesired vegetation, to the undesired plants or to a habitat thereof, a herbicidally effective amount of the compound of the present invention.
    Type: Application
    Filed: July 1, 2020
    Publication date: October 22, 2020
    Inventors: Itai BLOCH, Elad COHEN, Rachel AMIR, Maayan GAL
  • Patent number: 8937065
    Abstract: The invention relates to compounds and methods for modulating one or more components of a kinase signaling cascade.
    Type: Grant
    Filed: June 7, 2012
    Date of Patent: January 20, 2015
    Assignee: Clevexel Pharma
    Inventors: Oren M. Becker, Itai Bloch, Efrat Ben-Zeev, Alina Shitrit, Avihai Yacovan, Sharon Gazal, Vered Behar, Alexander Konson, Nili Schutz, Sima Mirilashvili, Gali Golan
  • Publication number: 20120316148
    Abstract: The invention relates to compounds and methods for modulating one or more components of a kinase signaling cascade.
    Type: Application
    Filed: June 7, 2012
    Publication date: December 13, 2012
    Applicant: Dynamix Pharmaceuticals LTD.
    Inventors: Oren M. Becker, Itai Bloch, Efrat Ben-Zeev, Alina Shitrit, Avihai Yacovan, Sharon Gazal, Vered Behar, Alexander Konson, Nili Schutz, Sima Mirilashvili, Gali Golan